AHS Cancer Control Alberta [clinicaltrials_resource:db3e695f932f6cf4d5cb691470ff4e1f]
Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Linda E Carlson, Ph.D [clinicaltrials_resource:09e15cd491b2345812fb2cfe22addbf1]Gino B. Fallone, PhD, FCCPH, DABR [clinicaltrials_resource:0a1dcd60e15d2e2e297d37635112c12e]Kerry Courneya, PhD [clinicaltrials_resource:0a56e6f04def7de66333d81975af23d1]Matthew Parliament, MD [clinicaltrials_resource:0de86eaca33d1bfb3ade3f060dea62dc]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Robert Pearcey, MD [clinicaltrials_resource:16cf137fe330a9ec0d1bfbf7769e286c]James Russell [clinicaltrials_resource:17c40ebffab2fb70141e43c86a6370d4]Alexander J. B. McEwan, MD, FRCPC [clinicaltrials_resource:1860b2a2f23ae7645fe534b9d34edadc]Don Yee, MD, FRCPC [clinicaltrials_resource:251474d8544638495bce872fb3179139]Alexander McEwan, MB, MSc, MD, FRCP [clinicaltrials_resource:2808c5e0e4437e95f872dcdf028f2399]Wilson Roa, MD [clinicaltrials_resource:2aac3aa16db0bc8f1a32a0eafd729486]Albert Murtha, MD, FRCPC [clinicaltrials_resource:2d5ac4c1e49aee81afbb6e5c94d7db75]Albert Murtha, MD [clinicaltrials_resource:2f0c890762daa372096331383ffb9475]Alexander J. B. McEwan, MD, FRCPC [clinicaltrials_resource:336164ed376f9618fa77dfb93d696046]Keith Wachowicz, PhD [clinicaltrials_resource:357e5016d09198ca9090bf25c22ea8c7]Carole Chambers, BSc. Pharmacy [clinicaltrials_resource:359bb5e8e7a9a70523675e87d731620a]Keith Wachowicz, PhD [clinicaltrials_resource:36580a197d4b6c9636c6b8d88c21cca2]Andrew Belch, MD [clinicaltrials_resource:3c19a27b770964d85d6c09e5c5c849c8]Naresh Jha, MBBS [clinicaltrials_resource:3fd836ba83811049cae6809abe097a3e]Harold Lau, M.D. [clinicaltrials_resource:400e7e0b85804f67090582f28b2a502d]Kerry Courneya, Ph.D. [clinicaltrials_resource:43e80092d345004932a592d36c44149d]Bassam Abdulkarim, MD, FRCPC [clinicaltrials_resource:440cb5dda006e31e49344a09ae04d992]Alexander J. B. McEwan, MD, FRCPC [clinicaltrials_resource:442f5d02bbef1d4e1a4048cfabdef4df]Jackson Wu [clinicaltrials_resource:579ec1444ea605398ebbf69d349574b1]Alexander McEwan, MB, MSc, MD [clinicaltrials_resource:5b4abfc6b143e0d02a3e6b17d4c4f815]Albert Murtha, MD, FRCPC [clinicaltrials_resource:5caa06788adb7d169150f5f8732b363b]Sandy McEwan, MD [clinicaltrials_resource:6144c996c1d6c029412511a803e68c2e]Albert Murtha, MD, FRCPC [clinicaltrials_resource:62fff2c1c0a8873f9ae48d5ecc77c86a]Kerry Courneya, Ph.D. [clinicaltrials_resource:65e2d58eab0d57ceb78b9975e08d3e9e]Harold P Lau, MD [clinicaltrials_resource:66acd9eeb833bf7b00dd040d6b36e17e]Harold P Lau, MD [clinicaltrials_resource:68375c9337c0dae300f9966a6a9d11e7]Don Yee, MD [clinicaltrials_resource:6c75cbeddcd5ef32d64a11121a69107b]Vera Mazurak, PhD [clinicaltrials_resource:71908908179ef54af474e67d5a38327d]Kurian J Joseph, MD, FRCPC [clinicaltrials_resource:71c3ff9faacef1df97c02682a991d86e]Sandy McEwan, MD [clinicaltrials_resource:7209cf7037749566565808b575d9a4fa]Kurian J Joseph, MD, FRCPC [clinicaltrials_resource:726b3efaabc09f90d3e09614dbd4254d]Kerry Courneya, Ph.D. [clinicaltrials_resource:78545b22efa833b2a802c8a7a0007408]Rufus Scrimger, MD, FRCPC [clinicaltrials_resource:7b8af865c39f2898a04d7c32daf9a8df]Peter Venner, M.D. [clinicaltrials_resource:7e8b82ac637060d04a7ef87f1484d4e9]
affiliation [clinicaltrials_vocabulary:affiliation]
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00322985]Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial [clinicaltrials:NCT00522262]Tomosynthesis in Screening Mammography [clinicaltrials:NCT01086241]clinicaltrials:NCT01129310A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation [clinicaltrials:NCT01133340]Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences [clinicaltrials:NCT01355185]A Prospective Phase I Study of Cyclotron-produced Tc-99m Pertechnetate (CPERT) in Patients With Thyroid Cancer [clinicaltrials:NCT01437254]clinicaltrials:NCT01624051Comparison Study of Family Practice Interventions for Depression in Adults [clinicaltrials:NCT01975207]A Study to See Whether Breath-Hold Techniques During Radiation Radiation Treatment Are Effective in Helping to Improve Sparing of the Heart [clinicaltrials:NCT02052102]clinicaltrials:NCT02080078clinicaltrials:NCT02152059clinicaltrials:NCT02187289clinicaltrials:NCT02206230Gem-HDM HDT and ASCT for Relapsed/Refractory Lymphoma [clinicaltrials:NCT02295722]clinicaltrials:NCT02439723
collaborator [clinicaltrials_vocabulary:collaborator]
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers [clinicaltrials:NCT00122239]Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection [clinicaltrials:NCT00123799]Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy [clinicaltrials:NCT00125697]Comparative 2-D Tumor Analysis in Familial Gliomas [clinicaltrials:NCT00125710]The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer [clinicaltrials:NCT00126802]Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment [clinicaltrials:NCT00126867]Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy [clinicaltrials:NCT00127816]Study of Tomotherapy in Patients With Benign Brain Tumour [clinicaltrials:NCT00128986]Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer [clinicaltrials:NCT00131599]Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function [clinicaltrials:NCT00137475]Trial of Combined Aerobic and Resistance Exercise in Breast Cancer Survivors [clinicaltrials:NCT00249015]A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00322985]clinicaltrials:NCT00323076Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology [clinicaltrials:NCT00330109]Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer [clinicaltrials:NCT00358098]An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine [clinicaltrials:NCT00414570]Tomotherapy Treatment for Mesothelioma [clinicaltrials:NCT00469196]A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia [clinicaltrials:NCT00497406]Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial [clinicaltrials:NCT00522262]A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours [clinicaltrials:NCT00566410]Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers [clinicaltrials:NCT00676286]Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating [clinicaltrials:NCT00690963]Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients [clinicaltrials:NCT00705094]A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical Tomotherapy [clinicaltrials:NCT00754078]Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer [clinicaltrials:NCT00756392]A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA [clinicaltrials:NCT00756691]Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy [clinicaltrials:NCT00765986]clinicaltrials:NCT00771381Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components [clinicaltrials:NCT00813787]Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer [clinicaltrials:NCT00888823]Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone [clinicaltrials:NCT00922519]A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma [clinicaltrials:NCT01065805]Tomosynthesis in Screening Mammography [clinicaltrials:NCT01086241]clinicaltrials:NCT01129310A Feasibility Study to Compare the Benefits of Endoscopic Tumor Clip Placement and 3T-MRI Simulation for Accurate Target Volume Definition for Rectal Cancer Patients Undergoing Pre-operative Chemoradiation [clinicaltrials:NCT01133340]Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients [clinicaltrials:NCT01157052]Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences [clinicaltrials:NCT01355185]Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer [clinicaltrials:NCT01411072]Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer [clinicaltrials:NCT01426841]Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer [clinicaltrials:NCT01428739]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers [clinicaltrials:NCT00122239]Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation [clinicaltrials:NCT00122252]Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer [clinicaltrials:NCT00122265]A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer [clinicaltrials:NCT00122291]Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00123747]Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer [clinicaltrials:NCT00123760]Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence [clinicaltrials:NCT00123773]Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma [clinicaltrials:NCT00123786]Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection [clinicaltrials:NCT00123799]Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy [clinicaltrials:NCT00123812]Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function [clinicaltrials:NCT00123864]Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation [clinicaltrials:NCT00124410]Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer [clinicaltrials:NCT00124423]Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix [clinicaltrials:NCT00124488]Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer [clinicaltrials:NCT00124930]Sublingual Methadone for the Management of Cancer Breakthrough Pain [clinicaltrials:NCT00125294]Bioavailability and Effectiveness of Transdermally Administered Morphine [clinicaltrials:NCT00125684]Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy [clinicaltrials:NCT00125697]Comparative 2-D Tumor Analysis in Familial Gliomas [clinicaltrials:NCT00125710]Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer [clinicaltrials:NCT00126165]Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community [clinicaltrials:NCT00126386]The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer [clinicaltrials:NCT00126802]Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy [clinicaltrials:NCT00126815]Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer [clinicaltrials:NCT00126828]Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Patients With Cancer of the Cervix [clinicaltrials:NCT00126841]High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation [clinicaltrials:NCT00126854]Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment [clinicaltrials:NCT00126867]Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy [clinicaltrials:NCT00127816]Study of Tomotherapy in Patients With Benign Brain Tumour [clinicaltrials:NCT00128986]Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00128999]Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00129012]Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer [clinicaltrials:NCT00129025]Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases [clinicaltrials:NCT00129051]Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [clinicaltrials:NCT00130936]Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma Proteins [clinicaltrials:NCT00131586]Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer [clinicaltrials:NCT00131599]An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment [clinicaltrials:NCT00131612]Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function [clinicaltrials:NCT00137475]Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG) [clinicaltrials:NCT00137488]HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma [clinicaltrials:NCT00144092]
source [clinicaltrials_vocabulary:source]
AHS Cancer Control Alberta [clinicaltrials_resource:db3e695f932f6cf4d5cb691470ff4e1f]
Bio2RDF identifier
db3e695f932f6cf4d5cb691470ff4e1f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:db3e695f932f6cf4d5cb691470ff4e1f
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:db3e695f932f6cf4d5cb691470ff4e1f
title
AHS Cancer Control Alberta
@en
type
label
AHS Cancer Control Alberta [clinicaltrials_resource:db3e695f932f6cf4d5cb691470ff4e1f]
@en